Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7028358
Reference Type
Journal Article
Title
Long-term outcomes of brachiobasilic transposition fistula for haemodialysis
Author(s)
Taghizadeh, A; Dasgupta, P; Khan, MS; Taylor, J; Koffman, G; ,
Year
2003
Is Peer Reviewed?
Yes
Journal
European Journal of Vascular and Endovascular Surgery
ISSN:
1078-5884
Publisher
W B SAUNDERS CO LTD
Location
LONDON
Page Numbers
670-672
PMID
14603429
DOI
10.1016/j.ejvs.2003.09.002
Web of Science Id
WOS:000186858900016
Abstract
Objectives. The transposed basilic vein to brachial artery arteriovenous fistula provides secondary vascular access for haemodialysis. The long-term results Of such fistula are assessed in this retrospective series.Material and methods. Over a 5-year period 75 brachiobasilic transposition fistulae were performed in 74 patients. There was a median follow up of 14 months.Results. Primary potency was achieved in 69 (92%) of the fistulae, and secondary potency in 74 (99%) of the fistulae. Successful interventions included angioplasties in four, and saphenous vein interposition in one, whilst three patients had failed thrombectomies. Dialysis was performed using 69 (92%) of the fistulae while 6 (8%) were never used. Of the 75 fistulae 47 (63%) were patent at follow up. Cumulative secondary potency was 66% at I year, 52% at 2 years, and 43% at 3 years. Complications developed in 41 (55%), and included thrombosis, infection, stenosis, arm oedema, bleeding, steal syndrome and microaneurysm formation.Conclusions. Brachiobasilic transposition fistulae have good long-term potency rates. The complication rate, although high, is lower than that reported for PTFE grafts. Brachiobasilic fistulae should be used in preference to PTFE grafts for secondary access.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity